In a clinical study with a small sample size, ZG16 expression was found to be sequentially downregulated from normal colon tissues and neoplastic precursor adenomatous polyps to COAD tissues (Meng et al., 2018). The gene discussed is ZG16; the disease is colon adenocarcinoma.